Studies on acid stability and solid-phase block synthesis of peptide–peptoid hybrids: ligands for formyl peptide receptors
- 186 Downloads
α-Peptoids as well as peptide/α-peptoid hybrids and peptide/β-peptoid hybrids constitute major classes of proteolytically stable peptidomimetics that have been extensively investigated as mimetics of biologically active peptides. Representatives of lipidated peptide/β-peptoid hybrids have been identified as promising immunomodulatory lead compounds, and hence access to these via protocols suitable for gram-scale synthesis is warranted to enable animal in vivo studies. Recent observations indicated that several byproducts appear in crude mixtures of relatively short benzyl-based peptide/β-peptoid oligomers, and that these were most predominant when the β-peptoid units displayed an α-chiral benzyl side chain. This prompted an investigation of their stability under acidic conditions. Simultaneous deprotection and cleavage of peptidomimetics containing either α-chiral α- or β-peptoid residues required treatment with strong acid only for a short time to minimize the formation of partially debenzylated byproducts. The initial work on peptide/β-peptoid oligomers with an alternating design established that it was beneficial to form the amide bond between the carboxyl group of the α-amino acid and the congested amino functionality of the β-peptoid residue in solution. To further simplify oligomer assembly on solid phase, we now present a protocol for purification-free solid-phase synthesis of tetrameric building blocks. Next, syntheses of peptidomimetic ligands via manual solid-phase methodologies involving tetrameric building blocks were found to give more readily purified products as compared to those obtained with dimeric building blocks. Moreover, the tetrameric building blocks could be utilized in automated synthesis with microwave-assisted heating, albeit the purity of the crude products was not increased.
KeywordsPeptidomimetics Peptoids Solid-phase synthesis Acid stability Formyl peptide receptor ligands
We acknowledge Birgitte Simonsen for the purification of peptidomimetics. NMR equipment used in this work was purchased via Grant No. 10-085264 from The Danish Research Council for Independent Research|Nature and Universe.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All authors listed have contributed to conception, design, synthesis, gathering, analysis, or interpretation of data, and have contributed to the writing and intellectual content of the article. All authors gave informed consent to the submission of this manuscript.
- Chongsiriwatana NP, Patch JA, Czyzewski AM, Dohm MT, Ivankin A, Gidalevitz D, Zuckermann RN, Barron AE (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci USA 105:2794–2799. https://doi.org/10.1073/pnas.0708254105) CrossRefPubMedGoogle Scholar
- Forsman H, Andréasson E, Karlsson J, Boulay F, Rabiet MJ, Dahlgren C (2012) Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin. J Immunol 189:629–637. https://doi.org/10.4049/jimmunol.1101616 CrossRefPubMedGoogle Scholar
- Garcia-Martin F, Quintanar-Audelo M, Garcia-Ramos Y, Cruz LJ, Gravel C, Furic R, Côte S, Tulla-Puche J, Albericio F (2006) ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides. J Comb Chem 8:213–220. https://doi.org/10.1021/cc0600019 CrossRefPubMedGoogle Scholar
- Goodson B, Ehrhardt A, Ng S, Nuss J, Johnson K, Giedlin M, Yamamoto R, Moos WH, Krebber A, Ladner M, Giacone MB, Vitt C, Winter J (1999) Characterization of novel antimicrobial peptoids. Antimicrob Agents Chemother 43:1429–1434. https://doi.org/10.1128/AAC.01080-10 CrossRefPubMedPubMedCentralGoogle Scholar
- Hein-Kristensen L, Knapp KM, Franzyk H, Gram L (2011) Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains. BMC Microbiol 11:144. https://doi.org/10.1186/1471-2180-11-144 CrossRefPubMedPubMedCentralGoogle Scholar
- Holdfeldt A, Skovbakke SL, Winther M, Gabl M, Nielsen C, Perez-Gassol I, Larsen CJ, Wang JM, Karlsson A, Dahlgren C, Forsman H, Franzyk H (2016) The lipidated peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 is a novel formyl peptide receptor 2 agonist that activates both human and mouse neutrophil NADPH oxidase. J Biol Chem 291:19888–19899. https://doi.org/10.1074/jbc.M116.736850 CrossRefPubMedPubMedCentralGoogle Scholar
- Kim J-K, Lee S-A, Shin S, Lee J-Y, Jeong K-W, Nan YH, Park YS, Shin SY, Kim Y (2010) Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of piscidin 1. Biochim Biophys Acta 1798:1913–1925. https://doi.org/10.1016/j.bbamem.2010.06.026 CrossRefPubMedGoogle Scholar
- Kirshenbaum K, Barron AE, Goldsmith RA, Armand P, Bradley EK, Truong KTV, Dill KA, Cohen FE, Zuckermann RN (1998) Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc Natl Acad Sci USA 95:4303–4308. https://doi.org/10.1073/pnas.95.8.4303 CrossRefPubMedGoogle Scholar
- Kruijtzer JAW, Hofmeyer LJF, Heerma W, Versluis C, Liskamp RMJ (1998) Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro) peptoids of Leu-enkephalin and substance P. Chem Eur J 4:1570–1580. https://doi.org/10.1002/(SICI)1521-3765(19980807)4:8%3c1570:AID-CHEM1570%3e3.0.CO;2-2 CrossRefGoogle Scholar
- Liu Y, Knapp KM, Yang L, Molin S, Franzyk H, Folkesson A (2013) High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis. Int J Antimicrob Agents 41:20–27. https://doi.org/10.1016/j.ijantimicag.2012.09.014 CrossRefPubMedGoogle Scholar
- Rothbard JB, Kreider E, Pattabiraman K, Pelkey ET, VanDeusen CL, Wright L, Wylie BL, Wender PA (2002) Arginine-rich molecular transporters for drugs: the role of backbone and side chain variations on cellular uptake. In: Langel Ü (ed) Cell-penetrating peptides: processes and applications. CRC Press LLC, Boca Raton, pp 142–160Google Scholar
- Shin SY (2014) Effect of double replacement of L-pro, D-pro, D-leu or Nleu in hydrophobic face of amphipathic α-helical model antimicrobial peptide on structure, cell selectivity and mechanism of action. Bull Korean Chem Soc 35:3267–3274. https://doi.org/10.5012/bkcs.2014.35.11.3267 CrossRefGoogle Scholar
- Skovbakke SL, Heegaard PMH, Larsen CJ, Franzyk H, Forsman H, Dahlgren C (2015a) The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2. Biochem Pharmacol 93:182–195. https://doi.org/10.1016/j.bcp.2014.11.004 CrossRefPubMedGoogle Scholar
- Skovbakke SL, Winther M, Gabl M, Holdfeldt A, Linden S, Wang JM, Dahlgren C, Franzyk H, Forsman H (2016) The peptidomimetic Lau-(Lys-βNSpe)6-NH2 antagonizes formyl peptide receptor 2 expressed in mouse neutrophils. Biochem Pharmacol 119:56–65. https://doi.org/10.1016/j.bcp.2016.09.004 CrossRefPubMedGoogle Scholar
- Skovbakke SL, Holdfeldt A, Nielsen C, Hansen AM, Perez-Gassol I, Dahlgren C, Forsman H, Franzyk H (2017) Combining elements from two antagonists of formyl peptide receptor 2 generates more potent peptidomimetic antagonists. J Med Chem 60:6991–6997. https://doi.org/10.1021/acs.jmedchem.7b00489 CrossRefPubMedGoogle Scholar